114 related articles for article (PubMed ID: 9770373)
1. Caspase-3-like activity is necessary for IL-2 release in activated Jurkat T-cells.
Posmantur R; Wang KK; Gilbertsen RB
Exp Cell Res; 1998 Oct; 244(1):302-9. PubMed ID: 9770373
[TBL] [Abstract][Full Text] [Related]
2. Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation.
Mukerjee N; McGinnis KM; Gnegy ME; Wang KK
Biochem Biophys Res Commun; 2001 Aug; 285(5):1192-9. PubMed ID: 11478781
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells.
Mack A; Häcker G
Eur J Immunol; 2002 Jul; 32(7):1986-92. PubMed ID: 12115619
[TBL] [Abstract][Full Text] [Related]
4. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells.
Chow SC; Slee EA; MacFarlane M; Cohen GM
Exp Cell Res; 1999 Feb; 246(2):491-500. PubMed ID: 9925765
[TBL] [Abstract][Full Text] [Related]
5. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
[TBL] [Abstract][Full Text] [Related]
6. Chymotryptic-type protease inhibitors block the increase in Ca2+ and Il-2 production in activated Jurkat T cells.
Auberger P; Mary D; Breittmayer JP; Aussel C; Fehlmann M
J Immunol; 1989 Feb; 142(4):1253-9. PubMed ID: 2521661
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade.
Gastman BR; Yin XM; Johnson DE; Wieckowski E; Wang GQ; Watkins SC; Rabinowich H
Cancer Res; 2000 Dec; 60(24):6811-7. PubMed ID: 11156370
[TBL] [Abstract][Full Text] [Related]
9. Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription.
Hofmann TG; Hehner SP; Dröge W; Schmitz ML
Oncogene; 2000 Feb; 19(9):1153-63. PubMed ID: 10713703
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells.
Jun DY; Kim JS; Park HS; Song WS; Bae YS; Kim YH
Toxicol Appl Pharmacol; 2007 Jul; 222(2):190-201. PubMed ID: 17559898
[TBL] [Abstract][Full Text] [Related]
11. Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates.
McGinnis KM; Gnegy ME; Park YH; Mukerjee N; Wang KK
Biochem Biophys Res Commun; 1999 Sep; 263(1):94-9. PubMed ID: 10486259
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
[TBL] [Abstract][Full Text] [Related]
13. Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell death.
Ludwiczek O; Kaser A; Koch RO; Vogel W; Cruikshank WW; Tilg H
Eur Cytokine Netw; 2001; 12(3):478-86. PubMed ID: 11566629
[TBL] [Abstract][Full Text] [Related]
14. Protease activation in apoptosis induced by MAL.
Köhler C; Håkansson A; Svanborg C; Orrenius S; Zhivotovsky B
Exp Cell Res; 1999 Jun; 249(2):260-8. PubMed ID: 10366425
[TBL] [Abstract][Full Text] [Related]
15. Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes.
Martelli AM; Cappellini A; Tazzari PL; Billi AM; Tassi C; Ricci F; Falà F; Conte R
Haematologica; 2004 Apr; 89(4):471-9. PubMed ID: 15075081
[TBL] [Abstract][Full Text] [Related]
16. Caspase-mediated degradation of T-cell receptor zeta-chain.
Gastman BR; Johnson DE; Whiteside TL; Rabinowich H
Cancer Res; 1999 Apr; 59(7):1422-7. PubMed ID: 10197606
[TBL] [Abstract][Full Text] [Related]
17. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2.
Guo H; Tittle TV; Allen H; Maziarz RT
Exp Cell Res; 1998 Nov; 245(1):57-68. PubMed ID: 9828101
[TBL] [Abstract][Full Text] [Related]
18. CD47 signals T cell death.
Pettersen RD; Hestdal K; Olafsen MK; Lie SO; Lindberg FP
J Immunol; 1999 Jun; 162(12):7031-40. PubMed ID: 10358145
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin 2 production but not methionine adenosyltransferase activity or S-adenosylmethionine turnover in Jurkat T-cells.
De La Rosa J; Geller AM; LeGros HL; Kotb M
Cancer Res; 1992 Jun; 52(12):3361-6. PubMed ID: 1596894
[TBL] [Abstract][Full Text] [Related]
20. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
